Tropomyosin isoforms as diagnostic biomarkers for bladder cancer

by N. Humayun-Zakaria, D.G. Ward, B. Abbotts, M.P. Zeegers, K. Cheng, N.D. James, R.T. Bryan, R. Arnold
Published 2020-07-01

The importance of lymph node location, burden and treatment outcome in M1 HSPC: analysis from the STAMPEDE trial arms A and C

by Á.M. Haran, A. Ali, A. Hoyle, T. Hambrock, C. Amos, Y. Jain, N.D. James, M.K.B. Parmar, M.R. Sydes, N.W. Clarke
Published 2020-09-01

Meta-analysis of six genome-wide association studies identifies novel loci associated with recurrence and progression of non-muscle invasive bladder cancer

by T. Galesloot, A.J. Grotenhuis, N.E. Fleshner, N.D. James, R.T. Bryan, K.K. Cheng, M.P. Zeegers, L. Mengual, J.W.F. Catto, D. Kolev, S.H. Vermeulen, L.A.L.M. Kiemeney
Published 2020-07-01

Replacing TURBT with mpMRI for staging MIBC: Pilot data from the BladderPath trial

by R.T. Bryan, S.J. Pirrie, W. Liu, R. Amir, J. Gallagher, A.I. Hughes, K.P. Jefferson, A. Knight, V. Nanton, H.P. Mintz, A.M. Pope, J.W.F. Catto, P. Patel, N.D. James
Published 2020-07-01